Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
In mammalians, toll-like receptors (TLR) signal-transduction pathways induce the expression of a variety of immune-response genes, including inflammatory cytokines. It is therefore plausible to assume that TLRs are mediators in glial cells triggering the release of cytokines that ultimately kill DA neurons in the substantia nigra in Parkinson disease (PD). Accordingly, recent data indicate that TLR4 is up-regulated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment in a mouse model of PD. Here, we wished to evaluate the role of TLR4 in the acute mouse MPTP model of PD: TLR4-deficient mice and wild-type littermates control mice were used for the acute administration way of MPTP or a corresponding volume of saline. We demonstrate that TLR4-deficient mice are less vulnerable to MPTP intoxication than wild-type mice and display a decreased number of Iba1+ and MHC II+ activated microglial cells after MPTP application, suggesting that the TLR4 pathway is involved in experimental PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TLR4 gene-deficient mice partially resist MPTP toxicity by suppressing the activation of microglia in the substantia nigra.156”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [156]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Self-citationMelanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Self-citationTargeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
LAFLAMME, N., & RIVEST, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0339com · Cited by 501
Moresco, E. M. Y., LaVine, D., & Beutler, B. (2011) · Current Biology · doi:10.1016/j.cub.2011.05.039 · Cited by 500
Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons
Stefanova, N., Fellner, L., Reindl, M., Masliah, E., Poewe, W., & Wenning, G. K. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.013 · Cited by 272
Ros-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231
Self-citationα-Synuclein Alters Toll-Like Receptor Expression
Béraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., & Maguire-Zeiss, K. A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00080 · Cited by 198
Hamre, K., Tharp, R., Poon, K. K.-Y., Xiong, X., & Smeyne, R. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01273-1 · Cited by 141
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease
Béraud, D., & Maguire-Zeiss, K. A. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70008-6 · Cited by 134
The chemokine stromal cell‐derived factor‐1/CXCL12 activates the nigrostriatal dopamine system
Skrzydelski, D., Guyon, A., Daugé, V., Rovère, C., Apartis, E., Kitabgi, P., Nahon, J. L., Rostène, W., & Parsadaniantz, S. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04639.x · Cited by 85
Self-citationModelling Parkinson‐like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
Alvarez‐Fischer, D., Guerreiro, S., Hunot, S., Saurini, F., Marien, M., Sokoloff, P., Hirsch, E. C., Hartmann, A., & Michel, P. P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05651.x · Cited by 75
Self-citationPanaro, M. A., Lofrumento, D. D., Saponaro, C., De Nuccio, F., Cianciulli, A., Mitolo, V., & Nicolardi, G. (2008) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970802278557 · Cited by 63
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity
Côté, M., Drouin‐Ouellet, J., Cicchetti, F., & Soulet, D. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.02.017 · Cited by 51
Depboylu, C., Schorlemmer, K., Klietz, M., Oertel, W. H., Weihe, E., Höglinger, G. U., & Schäfer, M. K.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.006 · Cited by 46
Self-citationThe role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
Drouin-Ouellet, J., Gibrat, C., Bousquet, M., Calon, F., Kriz, J., & Cicchetti, F. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-137 · Cited by 39 · cited 2×
“Drouin-Ouellet et al.(11) were unable to demonstrate a protective effect of MyD88 deletion, the downstream effector pathway to TLR4, against MPTP.”
BackgroundA CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females
Lin, J.-J., Chen, C., Yueh, K.-C., Chang, C. Y., & Lin, S. Z. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.010 · Cited by 30
Hopkins, W. J., Elkahwaji, J. E., Kendziorski, C. M., Moser, A. R., Briggs, P. M., & Suhs, K. (2008) · The Journal of Infectious Diseases · doi:10.1086/595987 · Cited by 16
Research works printed but not linked: 1
- Fahn S., Parkinsonism P. S., & Rowland L. P. ed. Meritt's neurology 10th ed. New York: Lippincott, 2000, 679–693 (2000).
Cited by
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Microglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 870
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response
Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza-Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 707
“These neurons project their axons from the SNpc to the striatum.”
BackgroundInfluentialLiu, W., Rong, Y., Wang, J., Zhou, Z., Ge, X., Ji, C., Jiang, D., Gong, F., Li, L., Chen, J., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1726-7 · Cited by 573
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
“observed that TLR-4 knockout lowered the number of activated microglial cells and protected against SN dopaminergic degeneration, demonstrating that TLR-4 contributes to neuroinflammation.(174) Adaptive immune responses also factor into neuroinflammation during PD.”
Background
Metadata
- Authors
- Noelker, C., Morel, L., Lescot, T., Osterloh, A., Alvarez-Fischer, D., Breloer, M., Henze, C., Depboylu, C., Skrzydelski, D., Michel, P. P., Dodel, R. C., Lu, L., Hirsch, E. C., Hunot, S., & Hartmann, A.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Bernhard Nocht Institute for Tropical Medicine (DE)
- Philipps University of Marburg (DE)
- Corresponding author
- Hunot, Stéphane
- Hartmann, Andreas
- ORCID
- Venue
- Scientific Reports
- Published
- 2013-03-06
- Volume
- 3
- Issue
- 1
- Pages
- 1393-1393
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3589722
- OpenAlex
- W2093718309
- Cited by
- 164
- References
- 23
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 9 · 2023: 14 · 2022: 10 · 2021: 17 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 10 · 2016: 15 · 2015: 12 · 2014: 11 · 2013: 2
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-01-16)
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- Deutsche Forschungsgemeinschaft
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Uniklinikum Giessen und Marburg
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- TLR4, Parkinson's disease, MPTP, dopaminergic neuron death, microglial activation, neuroinflammation, TLR4-deficient mice, substantia nigra, immune response
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Homovanillic Acid, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Cell Death, Microglia, Mice, Knockout, Parkinsonian Disorders, Toll-Like Receptor 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.